[HTML][HTML] A systematic review of artificial intelligence techniques in cancer prediction and diagnosis

Y Kumar, S Gupta, R Singla, YC Hu - Archives of Computational Methods …, 2022 - Springer
Artificial intelligence has aided in the advancement of healthcare research. The availability
of open-source healthcare statistics has prompted researchers to create applications that aid …

PP4R1 accelerates the malignant progression of NSCLC via up-regulating HSPA6 expression and HSPA6-mediated ER stress

X Zhu, X Chen, X Shen, Y Liu, W Fu, B Wang… - … et Biophysica Acta (BBA …, 2024 - Elsevier
Abstract Protein phosphatase 4 (PP4) plays an indispensable regulatory part in the
development and malignant progression of multifarious tumors. Nevertheless, the function of …

Computational resources for identification of cancer biomarkers from omics data

H Kaur, R Kumar, A Lathwal… - Briefings in Functional …, 2021 - academic.oup.com
Cancer is one of the most prevailing, deadly and challenging diseases worldwide. The
advancement in technology led to the generation of different types of omics data at each …

[HTML][HTML] Prognostic biomarkers for predicting papillary thyroid carcinoma patients at high risk using nine genes of apoptotic pathway

C Arora, D Kaur, LD Naorem, GPS Raghava - PLoS One, 2021 - journals.plos.org
Aberrant expressions of apoptotic genes have been associated with papillary thyroid
carcinoma (PTC) in the past, however, their prognostic role and utility as biomarkers remains …

[HTML][HTML] Risk prediction in cutaneous melanoma patients from their clinico-pathological features: superiority of clinical data over gene expression data

C Arora, D Kaur, A Lathwal, GPS Raghava - Heliyon, 2020 - cell.com
Risk assessment in cutaneous melanoma (CM) patients is one of the major challenges in
the effective treatment of CM patients. Traditionally, clinico-pathological features such as …

[HTML][HTML] A novel risk-score model with eight MiRNA signatures for overall survival of patients with lung adenocarcinoma

J Wu, Y Lou, YM Ma, J Xu, T Shi - Frontiers in Genetics, 2021 - frontiersin.org
Lung adenocarcinoma (LUAD) is the most common subtype of lung cancer with
heterogeneous outcomes and diverse therapeutic responses. To classify patients into …

Genetic predisposition to lung adenocarcinoma outcome is a feature already present in patients' noninvolved lung tissue

F Minnai, S Noci, M Chierici, CE Cotroneo… - Cancer …, 2023 - Wiley Online Library
Emerging evidence suggests that the prognosis of patients with lung adenocarcinoma can
be determined from germline variants and transcript levels in nontumoral lung tissue. Gene …

Universal and cross‐cancer prognostic biomarkers for predicting survival risk of cancer patients from expression profile of apoptotic pathway genes

C Arora, D Kaur, GPS Raghava - Proteomics, 2022 - Wiley Online Library
Numerous cancer‐specific prognostic models have been developed in the past, wherein
one model is applicable for only one type of cancer. In this study, an attempt has been made …

Biomarkers associated with metastasis and prognosis of lung adenocarcinoma based on microarray data.

J Du, H Qiao, DL Xie - General Physiology & Biophysics, 2022 - search.ebscohost.com
We attempted to discover the biomarker associated with metastasis and prognosis of lung
adenocarcinoma. The mRNA/lncRNA expression profiles (GSE101836) were downloaded …

Optimizing SVM Hyperparameters For Accurate Cancer Cell Classification

M Gupta, R Kumar, D Badala… - … Conference on New …, 2023 - ieeexplore.ieee.org
This research paper presents an optimized Support Vector Machine (SVM) algorithm for
accurate cancer cell classification. This algorithm utilizes the projection of data to higher …